The goal of this study was to investigate clinical outcomes and survival probabilities among
persons coinfected with human immunodeficiency virus (HIV) and human T lymphotropic …

To determine whether human T-lymphotropic virus (HTLV) type II coinfection affects
progression of human immunodeficiency virus type 1 (HIV) infection, longitudinal data on …

Coinfections with HIV-1 and HTLV-I or HTLV-II have been associated with unique
immunophenotypes and an increased risk for development of neurodegenerative …

Background. Human T lymphotropic virus types 1 (HTLV-1) and 2 (HTLV-2) are frequent
copathogens among individuals infected with human immunodeficiency virus type 1 (HIV-1) …

HIV/human T cell lymphotropic virus (HTLV) coinfection has a large range of prevalence in
the different risk groups and geographic regions of the world. Most of the HTLV-infected …

Important clinical effects of HTLV/HIV co-infection include the higher rates of myelopathy and
other neurological disorders and the poor predicative value of CD4+ cell counts as a …

Although early reports of an etiological role of HTLV-I in AIDS are not supported by
subsequent epidemiologic and biologic data, all AIDS specialists should be aware of the …

Serum samples from 895 HIV-1 infected individuals were tested for antibodies against HTLV-
I and HTLV-II. The overall prevalence of the co-infection was high (16.3%). Epidemiological …

Human T-cell leukemia/lymphoma virus type 1 (HTLV-1) infection is associated with
myelopathy/tropical spastic paraparesis (HAM/TSP) and adult T cell leukemia/lymphoma …

Background Recent data have shown that HTLV-1 is prevalent among HIV positive patients
in Mozambique, although the impact of HTLV-1 infection on HIV disease progression …